Antitüberküloz İlaçlara Karşı Konvansiyonel Duyarlılık Testleri

Yazarlar

Nuri Özkütük
https://orcid.org/0000-0002-2848-5914

Referanslar

Implementing the End TB Strategy: the essentials. Geneva: World Health Organization; 2015.

Della-Latta P (Ed.). Mycobacteriology and Antimycobacterial Susceptibility Testing. In: Leber AL (Ed.). Clinical microbiology procedures handbook. 4th ed. Washington: ASM Press; 2016. p. 7.1-7.9.

Global tuberculosis report 2025. Geneva: World Health Organization; 2025.

WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis. Geneva: World Health Organization; 2025.

European Centre for Disease Prevention and Control. Handbook on tuberculosis laboratory diagnostic methods in the European Union. Updated 2026. Stockholm: ECDC; 2026. doi:10.2900/8334202

CLSI. Susceptibility Testing of Mycobacteria, Nocardia spp., and Other Aerobic Actinomycetes. 3rd ed. CLSI standard M24. Wayne, PA; Clinical and Laboratory Standards Institute; 2018.

Forbes BA, Hall GS, Miller MB, Novak SM, Rowlinson MC, Salfinger M, et al. Practice guidelines for clinical microbiology laboratories: Mycobacteria. Clin Microbiol Rev. 2018 Apr 1;31(2).

Brown-Elliott BA, Cirillo DM, Musser KA, Rowlinson MC. Susceptibility Test Methods: Mycobacteria, Nocardia, and Other Actinomycetes. In: Carroll KC, et al., (eds.). Manual of clinical microbiology. 13th ed. Washington, USA: ASM Press; 2023. p. 1548–79.

Ulusal Mikrobiyoloji Standartları, Ulusal Tüberküloz Laboratuvar Rehberi. Ankara: T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü, Sağlık Bakanlığı Yayın No: 1413; 2026.

Tüberküloz Tanı ve Tedavi Rehberi. 3. baskı. Ankara: T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. Sağlık Bakanlığı Yayın No:1387; 2026.

Web Annex C. Technical manual for culture-based drug susceptibility testing of anti-tuberculosis drugs used in the treatment of tuberculosis. In: WHO operational handbook on tuberculosis. Module 3: diagnosis-rapid diagnostics for tuberculosis detection, third edition. Geneva: World Health Organization; 2024.

WHO operational handbook on tuberculosis. Module 3: Diagnosis. Geneva: World Health Organization; 2025.

Kent PT, Kubica GP. Public health mycobacteriology: a guide for the level III laboratory. Georgia: US Department of Health and Human Services, Public Health Service, Centers for Disease Control; 1985.

Guidance for the surveillance of drug resistance in tuberculosis. 6th ed. Geneva: World Health Organization; 2020.

O’Grady J, Maeurer M, Mwaba P, Kapata N, Bates M, Hoelscher M, et al. New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis. Curr Opin Pulm Med. 2011;17(3):134–41.

Palomino JC, Martin A, Von Groll A, Portaels F. Rapid culture-based methods for drug-resistance detection in Mycobacterium tuberculosis. J Microbiol Methods. 2008 Oct 1;75(2):161–6. doi:10.1016/J.MIMET.2008.06.015

Yıldırım D, Aldemir Ö, Yanık-Yalçın T, Parlak M. Isolation and Antibiotic Resistance Rates of Mycobacterium tuberculosis complex in Mycolor TK® System. Infectious Diseases & Clinical Microbiology. 2024 Dec 1;6(4):320. doi:10.36519/IDCM.2024.435

TİBO İnovatif Biyoteknoloji Organizasyonu Tic. Ltd. Şti. TK ANTI TB & PNB KIT Kullanım Yönergesi. [cited 2026 Oct 18]. Available from: https://tibobio.org/product/tk-anti-tb-pnb-kit/?lang=tr

Drobniewski F, Rüsch-Gerdes S, Hoffner S. Antimicrobial susceptibility testing of Mycobacterium tuberculosis (EUCAST document E.DEF 8.1) − Report of the Subcommittee on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis of the European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Clinical Microbiology & Infection. 2007;13(12):1144–56.

World Health Organization. Noncommercial culture and drug-susceptibility testing methods for screening patients at risk for multidrug-resistant tuberculosis Policy statement. Geneva: WHO; 2011.

Kontsevaya I, Werngren J, Holicka Y, Klaos K, Tran A, Nikolayevskyy V. Non-commercial phenotypic assays for the detection of Mycobacterium tuberculosis drug resistance: a systematic review. European Journal of Clinical Microbiology & Infectious Diseases. 2020;39:415–26. doi:10.1007/s10096-019-03723-8

Coban AY, Deveci A, Sunter AT, Martin A. Nitrate Reductase Assay for Rapid Detection of Isoniazid, Rifampin, Ethambutol, and Streptomycin Resistance in Mycobacterium tuberculosis: a Systematic Review and Meta-Analysis. J Clin Microbiol. 2014;52(1):15–9. doi:10.1128/JCM.01990-13

Kwak M, Lee WK, Lim YJ, Lee SH, Ryoo S. Systematic review and meta-analysis of the nitrate reductase assay for drug susceptibility testing of Mycobacterium tuberculosis and the detection limits in liquid medium. J Microbiol Methods. 2017;141:1–9. doi:10.1016/J.MIMET.2017.07.001

Coban AY, Deveci A, Sunter AT, Palomino JC, Martin A. Resazurin microtiter assay for isoniazid, rifampicin, ethambutol and streptomycin resistance detection in Mycobacterium tuberculosis: Updated meta-analysis. Int J Mycobacteriol. 2014;3(4):230–41. doi:10.1016/J.IJMYCO.2014.09.002

Moore DA, Evans CA, Gilman RH, Caviedes L, Coronel J, Vivar A, et al. Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of TB. New England Journal of Medicine. 2006;355(15):1539–50. doi:10.1056/NEJMoa055524

Toit K, Mitchell S, Balabanova Y, Evans CA, Kummik T, Nikolayevskyy V, et al. The Colour Test for drug susceptibility testing of Mycobacterium tuberculosis strains. Int J Tuberc Lung Dıs. 2012;16(8):1113–8. doi:10.5588/ijtld.11.0609

CLSI. Performance Standards for Susceptibility Testing of Mycobacteria, Nocardia spp., and Other Aerobic Actinomycetes. 2nd edition. CLSI supplement M24S. Clinical and Laboratory Standards Institute; 2023.

EUCAST reference protocol for MİK determination of anti-tuberculous agents against isolates of the Mycobacterium tuberculosis complex. (Version 8.2). 2025. [cited 2026 Oct 12]. Available from: https://www.eucast.org/mycobacteria/methodology-and-instructions/reference-method/

Wan Nor Amilah WAW, Mohammad Lukman Y, Siti Suraiya MN, Noor Izani NJ. Direct tetrazolium microplate assay (TEMA) for rapid drug susceptibility test screening of Mycobacterium tuberculosis. Trop Biomed. 2016;33(4):814–23.

Verma JS, Rawat D, Hasan A, Capoor MR, Gupta K, Deb M, et al. The use of E-test for the drug susceptibility testing of Mycobacterium tuberculosis – A solution or an illusion? Indian J Med Microbiol. 2010;28(1):30–3. doi:10.4103/0255-0857.58725

Yayınlanan

17 Kasım 2026

Lisans

Lisans